Upadacitinib Shows Potential for Ulcerative Colitis Upadacitinib Shows Potential for Ulcerative Colitis

Good efficacy and safety data provide hope for upadacitinib as an alternative JAK inhibitor for ulcerative colitis.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news